Metabolic reprogramming of macrophages in cancer therapy DOI
Xudong Wang, Shaolong Zhang,

Dixuan Xue

et al.

Trends in Endocrinology and Metabolism, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 1, 2024

Language: Английский

A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation DOI Creative Commons

Ziqi Ma,

Tao Zuo, Norbert Frey

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2024, Volume and Issue: 9(1)

Published: Sept. 23, 2024

Language: Английский

Citations

20

Dysbiosis and extraintestinal cancers DOI Creative Commons
Rui He,

Ping-Qian Qi,

Lin-Zhen Shu

et al.

Journal of Experimental & Clinical Cancer Research, Journal Year: 2025, Volume and Issue: 44(1)

Published: Feb. 7, 2025

Abstract The gut microbiota plays a crucial role in safeguarding host health and driving the progression of intestinal diseases. Despite recent advances remarkable correlation between dysbiosis extraintestinal cancers, underlying mechanisms are yet to be fully elucidated. Pathogenic microbiota, along with their metabolites, can undermine integrity barrier through inflammatory or metabolic pathways, leading increased permeability translocation pathogens. dissemination pathogens circulation may contribute establishment an immune-suppressive environment that promotes carcinogenesis organs either directly indirectly. oncogenic cascade always engages disruption hormonal regulation responses, induction genomic instability mutations, dysregulation adult stem cell proliferation. This review aims comprehensively summarize existing evidence points potential malignant transformation such as liver, breast, lung, pancreas. Additionally, we delve into limitations inherent current methodologies, particularly challenges associated differentiating low loads gut-derived microbiome within tumors from sample contamination symbiotic microorganisms. Although still controversial, understanding contribution translocated metabolites pathological continuum chronic inflammation could offer novel foundation for development targeted therapeutics.

Language: Английский

Citations

2

Desulfovibrio vulgaris flagellin exacerbates colorectal cancer through activating LRRC19/TRAF6/TAK1 pathway DOI Creative Commons
Yue Dong,

Fanyi Meng,

Jingyi Wang

et al.

Gut Microbes, Journal Year: 2024, Volume and Issue: 17(1)

Published: Dec. 24, 2024

The initiation and progression of colorectal cancer (CRC) are intimately associated with genetic, environmental biological factors. Desulfovibrio vulgaris (DSV), a sulfate-reducing bacterium, has been found excessive growth in CRC patients, suggesting potential role carcinogenesis. However, the precise mechanisms underlying this association remain incompletely understood. We have was abundant high-fat diet-induced Apcmin/+ mice, DSV, member Desulfovibrio, triggered colonocyte proliferation germ-free mice. Furthermore, level DSV progressively rose from healthy individuals to patients. Flagella important accessory structures bacteria, which can help them colonize enhance their invasive ability. that D. flagellin (DVF) drove proliferation, migration, invasion cells fostered xenografts. DVF enriched epithelial-mesenchymal transition (EMT)-associated genes characterized facilitation on EMT. Mechanistically, induced EMT through functional transmembrane receptor called leucine-rich repeat containing 19 (LRRC19). interacted LRRC19 modulate ubiquitination tumor necrosis factor receptor-associated (TRAF)6, rather than TRAF2. This interaction pivotal molecule TAK1, further enhancing its autophosphorylation ultimately contributing Collectively, interacts activate TRAF6/TAK1 signaling pathway, thereby promoting CRC. These data shed new light gut microbiota establish clinical therapeutic target.

Language: Английский

Citations

5

Turning cold into hot: emerging strategies to fire up the tumor microenvironment DOI
Kejing Ma, Lin Wang, Wenhui Li

et al.

Trends in cancer, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 1, 2024

Language: Английский

Citations

5

Serum metabolomic profiling for predicting therapeutic response and toxicity in breast cancer neoadjuvant chemotherapy: a retrospective longitudinal study DOI Creative Commons
Zhihao Fang, Guohong Ren,

Shouyu Ke

et al.

Breast Cancer Research, Journal Year: 2025, Volume and Issue: 27(1)

Published: Jan. 6, 2025

Neoadjuvant chemotherapy (NACT) is the standard-of-care treatment for patients with locally advanced breast cancer (LABC), providing crucial benefits in tumor downstaging. Clinical parameters, such as molecular subtypes, influence therapeutic impact of NACT. Moreover, severe adverse events delay process and reduce effectiveness therapy. Although metabolic changes during are determinant factors responses toxicities, related clinical research remains limited. One hundred paired blood samples were collected from 50 LABC before after a complete NACT cycle. Untargeted metabolomics was used by liquid chromatography-mass spectrometry (LC–MS) to investigate relationship between dynamically changing metabolites serum toxicities Firstly, we observed significant alterations metabolite levels pre- post-NACT, predominant enrichment sphingolipid amino acid metabolism pathways. Second, pre-treatment successfully predicted response hematotoxicities In particular, subtype variations favorable linked acyl carnitine levels. Finally, discovered that effects could be attributed essential metabolism. This study elucidated dynamic treatment, possibility developing responsive signatures personalized treatment.

Language: Английский

Citations

0

Link between dysbiosis and cancer: Contributing mechanisms and factors DOI

Naimah Turner,

Jocelynn Colunga-Minutti,

Sayan Alekseev

et al.

International review of cell and molecular biology, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Language: Английский

Citations

0

Recent advances in the role of high-salt diet in anti- and pro-cancer progression DOI Creative Commons
Shiwei Tang, Juan Xu, Ping Wan

et al.

Frontiers in Immunology, Journal Year: 2025, Volume and Issue: 16

Published: Jan. 29, 2025

Dietary behaviors significantly influence tumor progression, with increasing focus on high-salt diets (HSD) in recent years. Traditionally, HSD has been regarded as a major risk factor for multiple health issues, including hypertension, cardiovascular disease, kidney cancer, and osteoporosis. However, studies have uncovered novel aspect of HSD, suggesting that may inhibit growth specific pathological conditions by modulating the activity immune cells infiltrate tumors enhancing effectiveness PD-1 immunotherapy. This review focused duel molecular mechanisms cancer development, which are based microenvironment, gut microbiota, involvement sodium transporter channels. The objective this is to explore whether could be potential future oncological therapeutic strategy under situation.

Language: Английский

Citations

0

Harnessing amino acid pathways to influence myeloid cell function in tumor immunity DOI Creative Commons

Jiongli Pan,

Yi Lin,

Xinyuan Liu

et al.

Molecular Medicine, Journal Year: 2025, Volume and Issue: 31(1)

Published: Feb. 4, 2025

Abstract Amino acids are pivotal regulators of immune cell metabolism, signaling pathways, and gene expression. In myeloid cells, these processes underlie their functional plasticity, enabling shifts between pro-inflammatory, anti-inflammatory, pro-tumor, anti-tumor activities. Within the tumor microenvironment, amino acid metabolism plays a crucial role in mediating immunosuppressive functions contributing to progression. This review delves into mechanisms by which specific acids—glutamine, serine, arginine, tryptophan—regulate function polarization. Furthermore, we explore therapeutic potential targeting enhance immunity, offering insights novel strategies for cancer treatment.

Language: Английский

Citations

0

Complex Role of Circulating Triglycerides in Breast Cancer Onset and Survival: Insights From Two‐Sample Mendelian Randomization Study DOI Creative Commons
Wu Zhang, Zhiru Li,

Yuquan Huang

et al.

Cancer Medicine, Journal Year: 2025, Volume and Issue: 14(4)

Published: Feb. 1, 2025

ABSTRACT Background Reducing the incidence of breast cancer and improving its prognosis have become significant challenges for global public health sector. We aimed to investigate role circulating triglycerides in occurrence survival patients with cancer, while focusing on possible differential effects by molecular subtypes cancer. Methods used a Mendelian randomization approach analyze publicly accessible genome‐wide association study data, including triglyceride levels, risk, prognosis. performed two‐sample causality inference analysis using inverse‐variance weighted method. both randomization–Egger regression median methods model verification. Heterogeneity was evaluated Cochran's Q test, sensitivity analyses were leave‐one‐out method, intercept Randomization Pleiotropy RESidual Sum Outlier test. Results The results revealed negative causal relationship between levels overall risk (odds ratio [OR] = 0.94, confidence interval [CI] 0.89–0.99, p 0.011), luminal A (OR 0.93, CI 0.87–0.99, 0.014), human epidermal growth factor receptor 2 (HER2)‐enriched 0.84, 0.73–0.96, 0.010). However, no statistically correlations observed B, B HER2‐negative, triple‐negative subtypes. Furthermore, showed positive estrogen receptor‐negative 1.33, 1.00–1.76, 0.047). impact or receptor‐positive, HER2‐positive, HER2‐negative Conclusions potentially complex provides new perspective heterogeneity thereby promoting development precise medical strategies. Moreover, our findings contribute an increased understanding among clinicians alike.

Language: Английский

Citations

0

Synergistic regulation of colon microflora and metabolic environment by resistant starch and sodium lactate in hyperlipidemic rats DOI

Lu Liu,

Suzhen Lei,

Xiaoli Lin

et al.

International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: unknown, P. 141933 - 141933

Published: March 1, 2025

Language: Английский

Citations

0